Studies venturing into the roles of other biomarkers such as cystatin C, glycated albumin, and advanced glycation end-products, could provide a more comprehensive understanding of the correlation between glycemia and renal dysfunction. This evidence concerns the gene ALB and Abnormal renal physiology.